Primal Supplements Group Issues Recall of Men's Health Supplement

Primal Supplements Group, in collaboration with the U.S. Food and Drug Administration (FDA), has announced a voluntary recall of its men's health supplement, Primal Herbs Volume. The recall was initiated after it was discovered that the product contains sildenafil, the active ingredient found in Viagra, which is used to treat erectile dysfunction. Sildenafil is also prescribed under the brand name Revatio for pulmonary arterial hypertension, a condition characterized by high blood pressure in the lungs.

The Hill

The recall affects all orders of Primal Herbs Volume that were placed between July 2 and September 19, 2025. The product is packaged in an 8 1/2-ounce round container featuring a green label. Consumers are advised to cease using the supplement immediately and can request a replacement or store credit by contacting Primal Supplements Group via email at hello@primalherbs.com. Additional information regarding the recall is available on the FDA's website.

The Hill

The presence of sildenafil in Primal Herbs Volume poses potential health risks, particularly for individuals who may be unaware of its inclusion in the supplement. Sildenafil can interact with other medications and may not be suitable for everyone, especially those with certain medical conditions. The FDA's involvement underscores the seriousness of the situation and the importance of consumer safety.

The Hill

Primal Supplements Group has expressed its commitment to consumer safety and transparency, stating that the recall is a precautionary measure to protect customers. The company emphasized the importance of proper labeling and has taken steps to ensure that such an oversight does not occur in the future.

The Hill

While the recall aims to safeguard consumers, some critics have raised concerns about the regulatory oversight of dietary supplements. They argue that the lack of stringent labeling requirements can lead to similar incidents, potentially endangering public health. This incident highlights the ongoing debate regarding the regulation of supplements and the need for clearer guidelines to prevent such occurrences.

The Hill

As the recall process unfolds, Primal Supplements Group is expected to enhance its quality control measures and labeling practices. The FDA may also review its regulations concerning dietary supplements to prevent future incidents involving undisclosed pharmaceutical ingredients.

The Hill

“More details on the recall can be found on theFDA’s website.” — FDA Statement

The Hill